Search & Analyze

Dr. Reddy's Laboratories Ltd.

HealthcarePharmaceuticals & Drugs

www.drreddys.com BSE: 500124NSE: DRREDDY

₹1,145.00BSE0.43%

07 Sep, 4:01 PM

₹1,145.00

₹95.57K Cr

29.66

2.50

11.69%

₹1,161.00

₹1,142.55

₹1,414.40

₹1,080.05

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,899.80	37.69	4,55,825.66	0.84	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,305.00	84.45	2,47,018.51	0.32	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,913.00	85.68	1,86,874.73	0.77	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,155.00	25.53	1,15,211.69	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,395.95	33.46	1,12,773.00	0.93	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,868.25	92.32	1,00,943.83	0.11	362.07	123.94%	2,026.31	29.10%	18.20
LUPIN LTD. LUPIN	2,105.00	17.41	96,254.46	0.86	1,416.98	16.01%	8,276.89	32.04%	28.86
Dr. Reddy's Laboratories Ltd. DRREDDY	1,145.00	29.66	95,570.85	0.70	435.60	-69.10%	8,099.80	-5.51%	13.75

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	7,113.80	7,696.10	8,038.20	8,381.20	8,528.40	8,572.10	8,828.30	8,753.40	7,546.40	8,099.80
Expenses	5,282.60	5,566.20	5,961.70	6,108.20	6,530.50	6,398.50	6,818.40	6,865.90	7,163.90	7,239.90
	1,831.20	2,129.90	2,076.50	2,273.00	1,997.90	2,173.60	2,009.90	1,887.50	382.50	859.90
	25.74%	27.68%	25.83%	27.12%	23.43%	25.36%	22.77%	21.56%	5.07%	10.62%
	197.50	187.20	307.50	150.20	522.10	290.30	323.90	268.80	475.40	354.70
Interest	59.30	59.80	75.70	81.70	65.60	83.00	90.70	94.40	105.70	125.50
	367.70	380.60	397.00	471.40	454.70	476.10	504.60	521.00	557.10	536.60
	1,605.20	1,882.60	1,917.40	1,874.30	2,005.20	1,905.00	1,744.80	1,543.20	199.70	553.30
	18.40%	26.04%	30.01%	25.08%	20.87%	25.99%	23.38%	22.91%	-10.82%	21.27%
	1,309.80	1,392.40	1,255.70	1,413.70	1,593.30	1,418.10	1,347.10	1,209.90	220.90	444.30
	78.53	83.48	75.28	16.95	19.10	16.98	16.13	14.49	2.65	5.32

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	21,545.20	24,669.70	28,011.10	32,643.90	33,700.20
	21,545.20	24,669.70	28,011.10	32,643.90	33,700.20
EXPENDITURE :
Increase/Decrease in Stock	-353.90	70.90	-680.50	-544.70	-423.60
Raw Material Consumed	7,796.10	7,586.80	8,889.20	10,524.60	12,662.80
Power & Fuel Cost	390.50	477.40	533.90	562.50	556.50
Employee Cost	3,885.80	4,646.60	5,030.10	5,580.00	5,990.90
Other Manufacturing Expenses	1,602.20	1,738.60	2,087.20	2,563.20	2,242.70
General and Administration Expenses	1,547.60	1,497.50	1,848.20	2,173.20	2,084.40
Selling and Distribution Expenses	1,919.20	1,989.40	2,248.20	2,925.50	3,597.50
Miscellaneous Expenses	990.30	313.50	121.70	312.50	535.50
	17,777.80	18,320.70	20,078.00	24,096.80	27,246.70
Operating Profit (Excl OI)	3,767.40	6,349.00	7,933.10	8,547.10	6,453.50
	484.70	1,055.50	894.30	1,097.30	1,358.40
	4,252.10	7,404.50	8,827.40	9,644.40	7,811.90
Interest	95.80	142.80	171.10	282.90	373.80
PBDT	4,156.30	7,261.70	8,656.30	9,361.50	7,438.10
	1,165.20	1,250.20	1,470.00	1,703.70	2,058.80
Profit Before Taxation & Exceptional Items	2,991.10	6,011.50	7,186.30	7,657.80	5,379.30
	3,061.40	6,048.50	7,201.00	7,679.50	5,392.70
Provision for Tax	878.90	1,541.20	1,623.10	1,954.30	1,235.10
	2,182.50	4,507.30	5,577.90	5,725.20	4,157.60
Extra items				0.00	0.00
Minority Interest				-70.10	38.40
Consolidated Net Profit	2,182.50	4,507.30	5,577.90	5,655.10	4,196.00
Profit Balance B/F	14,239.50	16,034.10	20,022.80	24,998.00	30,052.20
Appropriations	16,422.00	20,541.40	25,600.70	30,653.10	34,248.20
Equity Dividend %	600.00%	800.00%	800.00%	800.00%	800.00%
	131.16	270.55	334.41	67.81	50.25
Adjusted EPS	26.23	54.11	66.88	67.81	50.25

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	83.20	83.30	83.40	83.40	83.50
Share Warrants & Outstandings	143.30	145.70	131.30	144.70	148.90
Total Reserves	18,985.90	23,057.10	28,040.10	33,321.50	37,659.10
Reserve excluding Revaluation Reserve	18,985.90	23,057.10	28,040.10	33,321.50	37,659.10
	19,212.40	23,286.10	28,254.80	33,549.60	37,891.50
Minority Interest				377.80	339.40
Secured Loans	194.60	127.80	219.00	406.40	1,220.30
Unsecured Loans	380.00		380.00	380.00
Deferred Tax Assets / Liabilities	-1,275.60	-629.20	-973.70	-428.70	-672.30
Other Long Term Liabilities	166.90	203.20	314.00	245.40	344.30
Long Term Provisions	25.80	19.90	23.90	29.80	33.80
Total Non-Current Liabilities	-508.30	-278.30	-36.80	632.90	926.10
Trade Payables	2,266.20	2,268.40	2,614.40	2,647.80	3,037.90
Other Current Liabilities	3,660.60	4,697.90	4,775.20	5,503.10	6,490.60
Short Term Borrowings	2,708.20	739.00	1,272.30	3,804.50	5,913.60
Short Term Provisions	1,130.80	866.80	926.10	1,078.40	1,305.30
Total Current Liabilities	9,765.80	8,572.10	9,588.00	13,033.80	16,747.40
Total Liabilities	28,469.90	31,579.90	37,806.00	47,594.10	55,904.40
Gross Block	23,096.40	25,567.10	24,527.40	36,759.60	43,854.30
Less: Accumulated Depreciation	14,894.90	16,348.00	14,101.30	18,533.20	21,494.10
Less: Impairment of Assets	80.00		0.50		296.90
Net Block	8,121.50	9,219.10	10,425.60	18,226.40	22,063.30
Capital Work in Progress	1,279.60	975.20	1,351.00	2,399.40	1,460.20
Non Current Investments	593.00	536.30	525.50	720.50	1,612.00
Long Term Investment	593.00	536.30	525.50	720.50	1,612.00
Long Term Loans & Advances	451.70	355.90	541.80	341.40	506.60
Other Non Current Assets	222.40	13.10	88.50	822.20	233.50
Total Non-Current Assets	10,682.00	11,154.50	13,000.70	22,576.10	25,875.60
Currents Investments	2,022.90	4,449.50	4,405.00	3,330.60	3,672.80
Inventories	5,088.40	4,867.00	6,355.20	7,108.50	7,653.40
Sundry Debtors	6,676.40	7,248.50	8,029.80	9,042.00	10,123.40
Cash and Bank	2,419.20	1,730.20	1,727.70	2,460.20	3,348.70
Other Current Assets	736.90	1,203.50	1,011.30	1,072.40	1,183.40
Short Term Loans and Advances	844.10	926.70	3,276.30	2,004.30	4,047.10
Total Current Assets	17,787.90	20,425.40	24,805.30	25,018.00	30,028.80
Net Current Assets (Including Current Investments)	8,022.10	11,853.30	15,217.30	11,984.20	13,281.40
Total Assets	28,469.90	31,579.90	37,806.00	47,594.10	55,904.40
Contingent Liabilities	107.60	107.20	109.10	83.04	336.14
Total Debt	3,384.50	1,347.20	2,002.00	4,676.60	7,734.10
	1,145.98	1,388.98	1,686.06	400.54	452.01
Adjusted Book Value	229.20	277.80	337.21	400.54	452.01

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	3,061.40	6,048.50	7,201.00	7,679.50	5,392.70
Adjustment	2,333.80	1,695.90	1,365.20	1,961.50	2,708.20
Changes In working Capital	-1,840.70	-785.50	-2,018.20	-2,998.90	-1,074.60
Cash Flow after changes in Working Capital	3,554.50	6,958.90	6,548.00	6,642.10	7,026.30
Cash Flow from Operating Activities	2,810.80	5,887.50	4,543.30	4,642.80	5,673.70
Cash Flow from Investing Activities	-2,638.70	-4,137.30	-4,028.30	-5,807.70	-6,549.30
Cash Flow from Financing Activitie	-242.20	-2,686.10	-376.30	1,891.10	829.00
Net Cash Inflow / Outflow	-70.10	-935.90	138.70	726.20	-46.60
Opening Cash & Cash Equivalents	1,482.00	1,485.20	577.90	710.70	1,459.30
Effect of Foreign Exchange Fluctuations	73.30	28.60	-5.90	22.40	124.10
Closing Cash & Cash Equivalent	1,485.20	577.90	710.70	1,459.30	1,536.80

Ratios

Valuation

29.66

2.50

15.23

2.93

38.60

457.39

Profitability

11.69

13.75

8.03

19.15

12.34

Leverage & Liquidity

0.20

1.79

15.43

Returns

0.70

0.65

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	26.65	26.64	26.64	26.64	26.64	26.64	26.64	26.63	26.64
	48.41	49.01	49.74	51.37	52.07	52.67	52.78	51.86	52.40
	10.36	10.13	10.38	10.44	10.26	9.86	9.71	9.57	9.55
	58.76	59.14	60.12	61.82	62.32	62.53	62.49	61.43	61.95
No. of Shareholders	2,67,694	3,10,403	4,03,669	4,59,605	4,51,929	4,49,216	4,55,243	4,49,665	4,46,086

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-06-30	AGM
2026-06-22	Board Meeting	Quarterly Results
2026-05-12	Ex Dividend	Rs.8.0000 per share(800%)Final Dividend	2026-07-10	2026-07-10

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)
2026-06-23	Tricia Wetzel	ESOP	Buy	4,275

Sector Overview

HealthcarePharmaceuticals & Drugs

Dr. Reddy's Laboratories Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

14 members across the board and senior leadership

K Randhir Singh

Company Secretary, Compliance Officer and Head-CSR

—

K Satish Reddy

Chairman

₹1.01 Cr

Mar '26

GV Prasad

Co-Chairman & Managing Director

₹1.58 Cr

Mar '26

GV Prasad

Co-Chairman & Managing Director

₹18.83 Cr

Mar '25

Leo Puri

Lead Independent Director

₹22.62 L

Mar '26

Arun Kumar